| Product & Indication | Pre-Clinical | Phase I | Phase II | Phase III | FDA Approval | |
|---|---|---|---|---|---|---|
| Intravenous citrulline | Acute lung injury induced by CPB | |||||
| Acute sickle cell crisis | ||||||
| Pre-Clinical | Phase I | Phase II | Phase III | FDA Approval |
|---|---|---|---|---|
| Product & Indication Intravenous citrulline | ||||
| Acute lung injury induced by CPB | ||||
| Acute sickle cell crisis | ||||
